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Abstract
Vitamin C (ascorbic acid) and vitamin B3 (niacin) have been extensively studied since the 20th century. In the
area of stem cell biology, vitamin C has shown its direct impact towards homeostasis and epigenetic changes.1
Vitamin B3 aids in maintaining healthy intestinal homeostasis and reducing gut inflammation by participating
in the rapamycin signaling pathway.2 In this study, vitamin C and vitamin B3 (600 and 1200 μg/ml) have been
explored as potential new biomaterials to study their effects on four types of intestinal stem cells which are
isolated from mice bearing different microbiota. We observed that C3H ASF and 129 ASF IL‐10 are more
sensitive towards 600 μg/ml vitamin B3 and 1200 μg/ml vitamin C. The lowest growth rate and viability for
all types of organoids was with 1200 μg/ml vitamin C. From qPCR analysis (quantitative Polymerase Chain
Reaction analysis), MUC2 was upregulated for 129 ASF and C3H Conv when exposed to 600 μg/ml and
1200 μg/ml vitamin C. It suggests that large amounts of glycoprotein may be produced after adding high
concentrations of vitamin C. Since inflammatory bowel disease has low level of MUC2, this finding may be
helpful in restoring mucosal health by upregulating the MUC2 gene while altering patient's microbiota.3
These results are expected to have a positive translational impact because this bottom‐up strategy would be
instrumental in developing Vitamin C and B3 based orally available therapeutic strategies and formula for
advancing the fields of gastrointestinal regenerative medicine.
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ABSTRACT 
Vitamin C (ascorbic acid) and vitamin B3 (niacin) have been extensively studied since the 20th 
century. In the area of stem cell biology, vitamin C has shown its direct impact towards 
homeostasis and epigenetic changes.1 Vitamin B3 aids in maintaining healthy intestinal 
homeostasis and reducing gut inflammation by participating in the rapamycin signaling 
pathway.2 In this study, vitamin C and vitamin B3 (600 and 1200 μg/ml) have been explored as 
potential new biomaterials to study their effects on four types of intestinal stem cells which are 
isolated from mice bearing different microbiota. We observed that C3H ASF and 129 ASF IL-10 
are more sensitive towards 600 µg/ml vitamin B3 and 1200 µg/ml vitamin C. The lowest growth 
rate and viability for all types of organoids was with 1200 µg/ml vitamin C. From qPCR analysis 
(quantitative Polymerase Chain Reaction analysis), MUC2 was upregulated for 129 ASF and 
C3H Conv when exposed to 600 µg/ml and 1200 µg/ml vitamin C.  It suggests that large 
amounts of glycoprotein may be produced after adding high concentrations of vitamin C. Since 
inflammatory bowel disease has low level of MUC2, this finding may be helpful in restoring 
mucosal health by upregulating the MUC2 gene while altering patient’s microbiota.3 These 
results are expected to have a positive translational impact because this bottom-up strategy 
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would be instrumental in developing Vitamin C and B3 based orally available therapeutic 
strategies and formula for advancing the fields of gastrointestinal regenerative medicine. 
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INTRODUCTION 
Inflammatory bowel diseases (IBD) affect nearly 3.1 million adults in the United States as of 
2015.4 IBD can range from having mild effects on people diagnosed with the disease, or they can 
drastically impact quality of life. Some ways in which this disease impacts the lives of people 
include abdominal pain and fatigue, chronic inflammation of the gut, as occurs in Crohn’s 
disease, as well as chronic ulceration and inflammation of the gut, as occurs in ulcerative colitis. 
The cause of these diseases is either genetic predisposition or by a disruption of the composition 
of the intestinal microbiota.5 By isolating intestinal stem cells, the intestine can be mimicked in 
order to obtain a better understanding of its microbiota, as well as of how IBD and other diseases 
of the gut can be cured or treated. 
 
In 2009, Toshiro et al. first isolated intestinal stem cells that continuously grew into the so-called 
“organoids”, providing an innovative new three dimensional model to study intestine.6 A minigut, 
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or organoid, is a self-renewable and self-assembling mini-organ that can keep differentiating and 
proliferating under a stabilized medium with determined growth factors or conditioned medium.7 
Compared with different types of epithelium cell lines, organoids can mimic intestinal 
epithelium layer formation processes through various cell signaling pathways.8 
 
Different from a monolayer, organoids can be considered as three dimensional systems that 
include different signaling pathways, different cell types, and different regions.9 There are two 
regions of organoid epithelium layers. The first region is called the villus-compartment, which 
contains enteroendocrine cells, enterocytes, and goblet cells.  Second region is called the crypt-
compartment, which includes the transient-amplifying (TA) region and the crypt base columnar 
(CBC) region, which includes Paneth cells and crypt base columnar cells.10 The way these cells 
interact with each other in the organoids is quite similar to the way they behave within the 
intestine. All of these cells have identical pathways, which are the (Wingless/Integrated) 
WNT/R-spondin signaling pathway that regulates cell proliferation and undifferentiated status 
and the BMP and Notch pathway that activates cell differentiation.11 Thus, the organoids have 
identical cell pathways and similar cell types when compared to the intestine epithelium itself. 
These advantages have been used to study various topics, such as modeling infectious diseases,12 
applications to different drug delivery systems,13,14,15,16,17,18 how they serve as a new drug loading 
material,19 various studies on nanomaterial’s toxicity,20 modeling different virus infections,21,22 
studying microbiota interactions23 and many more24,25,26,27.  
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By using this advanced model, we are able to take a look at the correlations between gut 
microbiota and vitamins C and B3. It is well-known that gut microbiota plays a very important 
role in regulating human health and controlling various diseases. For example, it has been shown 
that gut microbiota mediates the development of obesity-related metabolic disorders and insulin 
production. 28,29,30 Additionally, vitamins C and B3 impact Crohn’s disease, irritable bowel 
syndrome, and inflammatory bowel disease.31,32,33 Healthy microbiota can build healthy gut 
environments, which are beneficial in maintaining the intestinal immune system and for 
preventing inflammation.34 Recently, more and more studies have shown that there is 
bidirectional signaling between the development of the gut and the brain. Strong evidence has 
shown that gut microbiota plays a key role in modulating various signals through the gut-brain 
connection.  For instance, Benakis et al. has shown that ischemic brain injury was reduced after 
alterations in the intestinal flora by regulating intestinal T cells. 35 Additionally, Erny et al. has 
shown that host microbiota constantly control the maturation and function of microglia in the 
central nervous system using germ-free mice and altered Schaedler flora (ASF, defined flora)  
mice.36 
 
Vitamins play a key role in the human gut environment and in human health. Vitamin C 
(ascorbic acid) and vitamin B3 (Niacin) are water-soluble small molecules. Humans are unable to 
physiologically synthesize vitamin C in the body and therefore must introduce it through 
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different sources of food. It is important that humans consume vitamin C due to its role in the 
functionality of healthy organs and tissues, as well as for tissue reparation and regeneration.37, 30 
Vitamin C is absorbed from food by enterocytes through an ion channel. Vitamin B3, otherwise 
known as nicotinamide, nicotinic acid or niacin, is synthesized naturally in the body and is 
converted to NAD+. NAD+ is essential for many important processes in the body, one of which 
involves being reduced to NADH.38 Conversion of vitamin B3 to NAD+ takes place across the 
membranes of bacteria and mitochondria.39  
 
Additionally, it has been shown that vitamin C supports stem cell survival and differentiation.40 
There are two oxidoreductases located in the intestine that catalyze the transfer of electrons in 
order to recycle vitamin C for later use and that also enhance iron absorption. Vitamin C also 
affects the makeup and structure of extracellular matrix (ECM), which is an important influencer 
of stem cell behavior. ECM is involved in other signaling pathways that regulate cell 
proliferation and self-renewal. Vitamin B3 is an important precursor for coenzyme NAD+ and 
NADP synthesis. Studies have shown vitamin B3’s abilities in maintaining healthy intestinal 
hemostasis and reducing gut inflammation by participating in the rapamycin signaling pathway.41 
Additionally, some studies  have shown that vitamin B3 can be synthesized by large intestinal 
microbiota.42,43,44 It has also been shown that vitamin B3 is capable of alleviating severe 
intestinal colitis.45  
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Inspired by how the microbiota and vitamins C and B3 can influence intestinal development 
individually, we sought to explore vitamin C and B3 as new biomaterials to control stem cells 
fate for regenerative medicine. In particular, we were interested in seeing whether vitamins C 
and B3 have beneficial effects on different types of organoids. Thus, vitamin C and B3 (600 and 
1200 μg/ml) were chosen to study their effects on four different types of organoids which were 
isolated from a C3H/HeN defined-flora mouse (C3H ASF), a C3H/HeN Conventional Raised 
mouse (C3H Conv), a 129S defined-flora mouse (129 ASF), and a 129S defined-flora IL-10 
deficient (129 ASF IL-10) mouse. The C3H Conv and C3H ASF mice came from the same 
strain; however, the ASF mice only have eight specific bacterial species inside their GI tract, 
which are two Lactobacilli, one Bacteroides, one bacteria of the Flexistipes genus, and four 
Fusobacterium species.46  129 ASF and 129 ASF IL-10 mice both have the same types of 
microbiota species; however, the genetic backgrounds of these mice are different in that the IL-
10 gene has been knocked out in the 129 ASF IL-10 mice. IL-10 gene is a key gene for 
regulating immune response during infections.47 It is also a gene that associated with other 
cytokines, such as TNF-∂ 48, IL-17, IL-2349, and IL-450. Thus, by editing IL-10, the whole IL-10 
related pathway can be influenced, and it might cause significant phenotype changes.   
 
The motivation of using those four types of mouse is to gain the understanding of how vitamin C 
and B3 responds to different microbiota, as well as the inflammatory gut environments. By 
comparing C3H ASF to C3H Conventional strains, since the only difference between them is the 
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microbiota complexity, we can use those two types of mice to gain the understanding of how 
vitamins influenced organoids derived from different microbiota background. For comparing 
129S ASF and 129S ASF IL-10 knock-out organoids, Interleukin 10 gene (IL-10) is anti-
inflammatory related gene and served as a key immunoregulator during infections.47 By 
knocking out this gene, mouse has a strong tendency to develop gut colitis.51 Thus, by comparing 
129S ASF IL-10 knock-out mice with 129S  ASF, we can get some insights of how vitamin C 
and B3 reacts to an relatively inflamed gut environment by using organoids as a model. Thus, we 
can compare the influence of microbiota diversity (C3H CONV vs. C3H ASF), inflammation 
(129S ASF vs. 129S ASF IL-10 knock out), and different gene background (129S ASF vs. C3H 
ASF) by using organoids as an 3D gut model. Because of these differences among the four types 
of mice, this study can provide us a primary understanding of how various concentrations of 
vitamins influence intestinal health with complex gut, genetic, and strain backgrounds.   
 
MATERIALS AND METHODS 
Isolation of primary small intestinal crypts 
Primary small intestinal crypts were isolated from C3H/HeN strain mice colonized with a known 
microbiota, the Altered Schaedler Flora (ASF), as described by Peng et al.13 All different types 
of mice were obtained from the gnotobiotic murine colony housed at the College of Veterinary 
Medicine, Iowa State University. All animal procedures were conducted with the approval of the 
Iowa State University Institutional Animal Care and Use Committee (IACUC). All methods and 
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procedures in the experiments were performed in full compliance with the committee's 
guidelines and regulations. Following humane euthanasia and with all the procedures have been 
proved by IACUC, the small intestine was excised and cut into pieces of 1 to 2 mm in length, 
and tissue specimens were washed four to five times using ice-cold PBS. Subsequently, crypts 
were dislodged from the intestinal tissue using 2 mM EDTA buffer and centrifuged at 100 g for 
5 minutes at 4°C. Following re-suspension, the isolated crypt cells were implanted within 
Matrigel and added to a pre-heated 24-well plastic plate.  
 
Preparation of intestinal stem cell culture solution 
Advanced DMEM/F12 was purchased from Life Technologies, Carlsbad, CA, USA and Matrigel 
was purchased from Corning Inc., Corning, New York, U.S. Epidermal growth factor (EGF), 
noggin, and R-spondin-1 were purchased from PeproTech Inc. Rocky Hill, NJ, USA. Intestinal 
stem cell culture solution was prepared following the protocol provided by Peng et al.15 The 
culture medium was made by adding 2 mM GlutaMax, 10 mM HEPES, 100 µg/mL penicillin 
with 100 µg/mL streptomycin, N2 supplement (1×), B27 supplement (1×), 1 mM N-
acetylcysteine, 500 µg/mL R-spondin-1, 100 ng/mL noggin, and 50 ng/mL EGF to an Advanced 
DMEM/F12 solution.  
Vitamins C and B3 were purchased from Fisher Scientific, Pittsburgh, PA. In order to reach the 
required concentration, a 1000X stock solution was made for vitamins C and B3, which was 
diluted with culture solution for each experimental group. Organoids were isolated from 129 
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ASF IL-10, C3H Conv, C3H ASF, and 129 ASF mice. Different concentrations of vitamin C and 
B3 were added at day 1 of organoids’ culturing. 
 
Quantification of organoids growth rate 
Minigut growth was quantified at 5× magnification using bright-light microscopy with a bar 
scale. Thirty organoids were chosen randomly as representatives in each well and visualized 
using 5× magnification. Images taken at 5× magnification were used to measure surface area 
using ImageJ. First, the surface area growth rate for each minigut was calculated using the 
formula below: 
𝑀𝑖𝑛𝑖 𝑔𝑢𝑡 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑓𝑜𝑟 𝐷𝑎𝑦 # =
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑛 𝑡ℎ𝑒 # 𝑑𝑎𝑦 
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑛 𝑡ℎ𝑒 𝑓𝑖𝑟𝑠𝑡 𝑑𝑎𝑦 
 
# represents Day 1, 2, 3, 4, 5, 6, or 7. 
Second, the surface area for each day was plotted linearly and the slopes were used for box plots. 
Statistical analysis, including two-way ANOVA test and Tukey test, was performed using JMP® 
statistical software.  
 
Live/dead cell staining morphology 
For live/dead cell viability staining, live/dead® reduced biohazard viability/cytotoxicity kit #1 
(L-7013) was purchased from Thermo Fisher Scientific, Waltham, MA, USA. Culture medium 
was removed and 500 μL of HEPES-buffered saline solution (HBSS) was added in each well for 
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washing. Components A and B from the kit (2 µL of each) were pipetted into 1 mL of HBSS. In 
each well, 300 μL of the solution was added and incubated in the dark for 30 min. Then, the dye 
solution was removed, and the wells were washed with fresh HBSS. Live/dead cells were 
observed and quantified under a fluorescence microscope. 
 
Quantification of minigut viability via modified MTT method 
The metabolic activities of organoids after eleven days incubation for each treatment group (600 
μg/ml vitamin C, 1200 μg/ml vitamin C, 600 μg/ml vitamin B3, 1200 μg/ml vitamin B3 and 
control) were normalized by culturing with 10 mg/mL resazurin (Sigma-Aldrich, St. Louis, MO, 
USA) for 6 h at 37°C and 5% CO2. Fluorescence was recorded using 544 nm excitation/590 nm 
emission. Then, 5 mg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
was added to the culture medium at a 1:10 dilution and incubated for 2 h in the same condition as 
before. After 2 h, the culture medium was removed and 200 μL of 2% sodium dodecyl sulfate 
(20% SDS, Sigma-Aldrich, St. Louis, MO, USA) was added and incubated for 2 h to solubilize 
the Matrigel. Then, 200 μL of dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO, USA) 
was added to each well and incubated for 2.5 h. Absorbance was read at 570 nm on an optical 
plate reader. Then, absorbance at 570 nm for each well was normalized with the absorbance of 
resazurin using the formula below:  
𝐴𝑏𝑠(𝑀𝑇𝑇) =
𝐴𝑏𝑠(570 𝑛𝑚)  ×  10000
𝐴𝑏𝑠(𝑟𝑒𝑠𝑎𝑧𝑢𝑟𝑖𝑛)
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Quantitative PCR analysis 
Matrigel was removed from organoids by treating with 1000 μl of Cell Recovery Solution 
(Corning Life Sciences) with shaking for 1 hour at 4°C followed by PBS washes. Total RNA 
was extracted by using a RNeasy Mini Kit (Qiagen, Valencia, CA) and the procedure was 
performed by following its manual. Concentrations and purifications of RNA was checked by 
NanoDrop® spectrophotometers. Primers were purchased from the DNA facility, Iowa State 
University, Ames, IA. Power SYBR™ Green RNA-to-CT™ 1-Step Kit was used. Later, gene 
expression differences were normalized by using housekeeping genes. 2-∆∆CT values were 
calculated and analyzed. Primers are listed as Table 1. 
 
RESULTS 
Experimental design for comparing gut flora and genetic differences 
For this study, as shown in Scheme 1, four types of mice were used. There were C3H/HeNRj 
Conventional Raised mice (C3H Conv), C3H/HeNRj Altered Schaedler Flora (C3H ASF) mice, 
129S2/SvPasOrlRj Altered Schaedler Flora (129 ASF) mice, and 129S2/SvPasOrlRj Altered 
Schaedler Flora IL-10 knock out (129 ASF IL-10) mice.  Intestinal stem cells were isolated from 
them and used for growing organoids. On the first day, 600 µg/ml or 1200 µg/ml of vitamin B3 
or vitamin C were added to the cell culture solutions and the organoids were observed for seven 
days. For this study, there are five experimental groups (control: culture solution only; C600: 
vitamin C 600 µg/ml; B600: vitamin B3 600 µg/ml, C1200: vitamin C 1200 µg/ml, and B1200: 
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vitamin B3 1200 µg/ml). There are also four different types of organoids used for each 
experimental group, which are C3H Conv, C3H ASF, 129 ASF, and 129 ASF IL-10. In total, 
there are 20 different ways to compare the data.  
 
Organoids growth rate comparisons  
In order to analyze how different concentrations of vitamins C and B3 influenced organoids, 
growth rates of the organoids were plotted, as shown in Figure 1 and Figure 2. In Figure 1, 
comparisons were made between the same mouse strain and different vitamin concentrations. 
Vitamin B3 600 and 1200 µg/ml and vitamin C 600 and 1200 µg/ml were also compared with 
the control for the same types of organoids individually. Figure 1a shows the growth rate of 129 
ASF under different concentrations of vitamins. The results, when compared with its control 
group, showed that the growth rate for the 129 ASF organoids after adding vitamin C 1200 
µg/ml is significantly decreased. As shown in Figure 1b, after adding Vitamin C 1200 µg/ml, the 
growth rate for 129 ASF IL-10 was also significantly decreased. Despite the decreasing growth 
rates for C1200 groups, there is a slight increase in the growth rates for vitamin B3 600 µg/ml 
that is significant for the 129 ASF IL-10 organoids. In Figures 1c and 1d, both C1200 group 
show a significant decreased growth rate. However, as shown in Figure 1d, B600 has increased 
growth rates when compared with the control for C3H ASF organoids. From this figure, we are 
able to conclude that the addition of 1200 µg/ml of vitamin C decreased growth rates for all 
types of organoids and that the 600 µg/ml of vitamin B3 increased growth rates. In Figure 2, the 
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growth rate data from Figure 1 was replotted to compare different organoids cultured with the 
same vitamin condition. For Figure 2a, b and c, which we compared the growth rate for 
conditions under 600 µg/ml of Vitamin C and 1200 µg/ml of Vitamin B3, however, there is no 
significant growth rate differences according to p-values. 
 
Live/dead cell fluorescence image morphology and quantification 
In addition to the growth rate comparisons among the organoids, a live/dead fluorescence end 
point test was performed on the last day of the experiment. Organoids were randomly selected 
and stained where green indicates live cells and red color indicates dead cells within each 
organoid. All images were taken under the same exposure time and 10 X magnification. Using 
the live/dead imaging from Figure 3, the live/dead fluorescence ratio was calculated and 
quantified for comparison (Figures 4a and 4b). Higher fluorescence ratios correspond to higher 
levels of live cells. After an ANOVA test and Tukey test, the majority of the ratios did not show 
any significant difference. 
 
Quantitative viability test for organoids  
In order to have a better understanding of cell viability, a colorimetric (3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) MTT assay was performed as an end point test. MTT 
results for each type of organoid were plotted as Figures 5a and 5b. Figure 5c summarizes the p 
values calculated from the Tukey statistical test from Figure 5a. 
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Gene expression analysis using qPCR 
In Figure 6 gene expression levels were compared for different vitamin concentrations with the 
same type of organoids. For C3H Conv organoids, C3H Conv C600, C1200, B600 and B1200 
are compared with C3H Conv control. For C3H ASF organoids, C3H ASF C600, C1200, B600 
and B1200 are compared with C3H ASF control. For 129 ASF organoids, 129 ASF C600, C1200, 
B600 and B1200 are compared with 129 ASF control. For 129 ASF IL-10 organoids, 129 ASF 
IL-10 C600, C1200, B600 and B1200 are compared with 129 ASF IL-10 control group. For 
these images, red indicates higher gene expression compared to the control group (0 µg/ml 
vitamins) and green indicates inhibition of gene expression compared to control. Black indicates 
no difference between the control group and the other group.  In Figure 7 quantitative PCR 
results were replotted and organized based on cell types. 
 
DISCUSSIONS 
Among the 20 ways of comparison, there are a couple of major comparisons that of particular 
interest. These can be categorized into two different, major comparison groups. We will compare 
the influence of vitamins on each type of organoid individually, and we will also compare the 
influence of organoid type on each vitamin concentration. For example, we want to know how 
vitamin C at a concentration of 600 µg/ml influenced the 129 ASF organoids. We are also able to 
make a comparison between how 129 ASF and 129 ASF IL-10 differed at a concentration of 600 
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µg/ml for vitamin C. With these two different comparisons, we can use the collected data 
extensively. By comparing C3H Conv and C3H ASF under the same experimental group (control, 
C600, C1200, B600, and B1200), we can gain some insights on how the microbiota influenced 
the organoids. 
 
 By comparing C3H ASF with 129 ASF under the same experimental group (control, C600, 
C1200, B600, and B1200), we can obtain insight on the role that strain differences play when 
vitamins are added to the medium. By comparing 129 ASF with 129 ASF IL-10, we were able 
obtain insight on how the IL-10 knock out gene influenced organoids under same amounts of 
vitamin concentrations. Along with those three comparisons, we were also able to make 
comparisons within the same type of organoids on how different concentrations of vitamins 
changed the cells by comparing them (C600, B600, C1200, B1200) with the control (0 µg/ml of 
vitamins).  
 
In regard to Figure 2, we are particularly interested in how the different types organoids are 
stressed under the same amount of vitamin concentrations. By using ANOVA and Tukey tests, 
there are two concentrations that show significant differences among the different types of 
organoids. These significant differences are shown in Figures 2d and 2e. In Figure 2d, vitamin C 
1200 µg/ml was plotted for the four organoid types. C3H ASF has a lower growth rate compared 
to C3H Conv (p = 0.0074). C3H ASF also has a lower growth rate than 129 ASF. There is no 
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statistical significance between 129 ASF IL-10 and 129 ASF under 1200 µg/ml of vitamin C. In 
Figure 2e, vitamin B3 600 µg/ml was plotted for each organoid. For this concentration, C3H 
CONV has a lower growth rate than C3H ASF. It is interesting to see that C3H ASF organoids 
are more sensitive to vitamin supplementation compared to the other types of organoids.  
From Figure 3, 129 ASF IL-10 and C3H ASF organoids have more dead cells compared to the 
129 ASF and C3H Conv organoids. Additionally, the green color is more intense for 129 ASF 
IL-10 and 129 ASF compared to C3H ASF and C3H Conv. From the bright field images, it is 
noticeable that 1200 µg/ml vitamin C disrupted the crypt structures and the integrity of the 
organoids. Furthermore, after adding 600 µg/ml of vitamin B3 to each type of organoid, there 
appeared to be an increased number of crypts compared to control.  For C3H Conv, 1200 µg/ml 
and 600 µg/ml of vitamin B3 appeared to be healthier than control due to the organoid’s larger 
size and increased number of crypts. 
 
One exception can be seen in comparing C600 and control of the C3H organoids, in which the 
C600 organoid had a higher fluorescence ratio than control. In Figure 4b each organoid type was 
compared with identical vitamin supplementation. Although there is no statistical significance 
difference, C3H ASF and C3H Conv have lower ratios compared to 129 ASF and 129ASF IL-10. 
In Figures 5a and 5c vitamin concentrations were compared with control groups for each type of 
organoid individually. The results are consistent with the growth rates (Figures 1 and 2) with 
significant decreases in cell viability for 1200 µg/ml vitamin C. Additionally, 600 µg/ml of 
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vitamin C also decreased cell viability for C3H Conv, C3H ASF, and 129 ASF IL-10 organoids. 
Additionally, for Vitamin B3 600 µg/ml, there is a slight decrease in cell viability for C3H ASF. 
In Figure 5b, MTT results were plotted based on vitamin concentration. Interestingly, the 129 
ASF IL-10 control organoids are more viable compared with the other controls. Additionally, 
there was is a slight decrease in viability for the B1200 group for C3H ASF organoids compared 
to the other organoid types. 
In order to understand the reason behind why the growth rates and cell viabilities differed across 
animal strains and vitamin concentrations, seven genes that influence cell proliferation were 
selected (PIK3CA, CD44, Ki67, NF-kB, Ceacam 12, MUC2, and IL-10). The PIK3CA gene is 
responsible for controlling cell signaling, including the production of new cells, cell growth, and 
proliferation.52 The CD44 protein is a cell-surface glycoprotein that is related to cell-cell 
interaction and lymphocyte activity.53 Ki67 contributes to controlling cell proliferation and the 
cell cycle.54 NF-kB, which is nuclear factor kappa light enhancer of activated B cells, is a 
complex of proteins that controls DNA transcription, cytokine production, and cell survival 
fate.55 Ceacam 12 is a member of the CEACAM gene family, which is a family of a 
Carcinoembryonic antigen-related cell adhesion molecules. This gene is related to tumor 
progression and metastasis. It is mostly found in the epithelium layer.56 MUC2 (Mucin 2) is 
related to goblet cells in the intestinal epithelium, which play a key role in protecting the 
epithelium layer.57  IL-10 (Interleukin 10) is a gene related to inflammation. With IL-10 and its 
potent anti-inflammatory properties, it has served as a key role in maintaining immune responses 
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towards pathogens, and host inflammatory responses.58 As shown in Figures 6 and 7, quantitative 
PCR was performed and analyzed.  
 
MUC2 was upregulated in vitamin C groups and downregulated in Vitamin B3 groups (Figure 6). 
MUC2 is secreted by goblet cells in the gut epithelial barrier and is a major secreted intestinal 
mucin. We know from Figures 1, 2 and 3 that high concentrations of vitamin C, 1200 µg/ml 
especially, disrupted the cell structure and results in lower growth rate and cell viability. 
However, MUC2 is also significantly upregulated for C3H Conv C1200 and 129 ASF C600 
groups. Thus, upregulated signaling of MUC2 could be due to goblet cells in organoids somehow 
sensing the disruption, and are preparing for reparation and protection of the epithelial cells.59  
From Parlato et al.59 a signal transduction pathway involving MUC2 and NF-kB for intestinal 
epithelial tissue repair has been mentioned. After the disruption of the intestinal epithelial layer, 
goblet cells will start secreting MUC2 and then TFF3 will be released and detected by 
enterocytes. After, NF-kB, p38, and ERK will be activated for cell differentiation and restitution. 
However, based on Figure 6, NF-kB gene expression for most experimental groups was 
downregulated or had no differences compared with control. This indicated that, although MUC2 
might be secreted, cell reparation had failed. This could due to TFF3 release being unsuccessful.  
 
PIK3CA mutation has been associated with endometrial, breast, and colorectal cancers.60 
Upregulation of PIK3CA can induce cell amplification and proliferation.61 PIK3CA is highly 
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expressed in organoids from the 129 ASF mouse strain compared with the C3H ASF strain 
(Figure 7a). Although most of the genes are downregulated and are not statistically different, 
PIK3CA expression in 129 ASF B600 is upregulated compared with control (p < 0.0001). 
Additionally, the majority of vitamin B groups are upregulated, and vitamin C groups are 
downregulated for PIK3CA. 
 
Additionally, most of the 129 ASF groups are upregulated for MUC2 and IL-10 expression 
compared with C3H ASF. This strain difference can give us some insights regarding which one 
to choose for different studies. For instance, 129 ASF is more sensitive to cell disruptions and 
would be a better model for inflammatory bowel disease. Figure 7b compares 129 ASF and 129 
ASF IL-10. We were anticipating upregulation of IL-10 expression in 129 ASF compared with 
129 ASF IL-10 since the IL-10 gene was knocked out in the 129 ASF IL-10 strain. However, 
there was no statistically significant difference between these groups. All experimental groups 
resulted in downregulation of IL-10. IL-10 is known to be produced by macrophages, dendritic 
cells, B cells, and various T cells.47 The reason for this downregulation could due to the fact that 
organoids lack those immune-related cell types and that they only have epithelium. It could also 
due to the organoids having lost their ability for regulating the IL-10 gene during cell culturing. 
Figure 7c shows that most of the gene expressions are neutral, with the exception that NF-kB for 
the C3H ASF B600 group is slightly upregulated. Additionally, PIK3CA for C1200 is also 
upregulated for C3H ASF compared to C3H Conv.  
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CONCLUSION 
Based on our cell viability, live/dead staining, live/dead fluorescence ratios, and cell growth rate 
results, we suggest that C3H ASF organoids are more sensitive to vitamins B3 and C compared 
to the other organoids studied here. Higher concentrations of vitamin C tended to cause reduction 
in cell sizes, decreasing in growth rates but upregulation for MUC2. Adding 600 µg/ml of 
vitamin B3 to the organoids lead to higher growth rates, an increase in the number of crypts, and 
viable organoids compared with control groups. From the qPCR analysis, MUC2 and PIK3CA 
gene expression had the most significant regulation, where 1200 µg/ml vitamin C tended to 
result in an upregulation of MUC2, and 600 µg/ml B600 tended to cause a downregulation of 
PIK3CA. Differences in gene expression levels were also influenced by mouse strain. When 
comparing 129 ASF with C3H ASF, MUC2 and IL-10 genes tended to be upregulated. MUC2 
was downregulated for 129 ASF organoids compared to the 129 ASF IL-10 organoids.  
 
Here, we provide some insights connecting vitamins with different microbiota environment, 
different strain backgrounds, and different genetic backgrounds. It is interesting to see that strain 
differences are affected differently for the same concentrations of vitamins. With this 
comparison, a concentration dependent vitamin C or B3 dose might be applied in vivo to 
intestinal diseases.  These results are expected to have a positive translational impact because 
this bottom-up strategy would be instrumental in developing Vitamin C and B3 based orally 
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available therapeutic strategies and formula for advancing the fields of gastrointestinal 
regenerative medicine. 
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TABLE AND FIGURE CAPTIONS 
Table 1. Primers used for qPCR experiment.  
 
Scheme 1. Experimental design flowchart for testing effects of vitamin C and B3 on organoids. Blue, 
red, black and green colored dots represent organoids isolated from different types of mice. Four different 
colored mice represent C3H/HeNRj Conventional Raised mice (Blue), C3H/HeNRj defined-flora mice 
(Red), 129S2/SvPasOrlRj Altered Schaedler Flora mice (Black), and 129S2/SvPasOrlRj Altered 
Schaedler Flora IL-10 knock out mice (Green).  
 
Figure 1. Organoids growth rate comparison under same organoids type. Thirty random 
organoids were tracked every day using 5x magnification and the surface area for each organoid 
was plotted linearly. Slopes from each linear regression were recorded and used. Five number 
summaries (Maximum, Minimum, Medium, 1st quartiles and 3rd quartiles) are shown in this plot 
for each experimental group. Two-way ANOVA and Tukey tests were used to calculate 
significances with a null hypothesis H0: Under the same type of organoids (C3H Conv, C3H ASF, 
129S ASF, or 129S ASF IL-10), there is no growth rate differences between control and the 
other experimental groups (C600, B600, C1200 or B1200).  Alpha value set at 0.05. * p-value 
<0.05; ** p-value <0.01; *** p-value <0.001. a) 129S ASF, b) 129 ASF IL-10, c) C3H Conv, 
and d) C3H ASF.  
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Figure 2. Organoids growth rate comparison under each same concentration groups. Thirty 
random organoids were tracked every day using 5x magnification and the surface area for each 
organoid was plotted linearly. Slope from each linear regression was recorded and used. Five 
number summaries (Maximum, Minimum, Medium, 1st quartiles and 3rd quartiles) are shown in 
this plot for each experimental group. Two-way ANOVA and Tukey tests were used to calculate 
significances with a null hypothesis H0: Under the same concentrations (C600, B600, C1200 or 
B1200), there is no growth rate differences between each organoid type (C3H Conv, C3H ASF, 
129S ASF, or 129S ASF IL-10). Alpha value set at 0.05. * p-value <0.05; ** p-value <0.01; *** 
p-value <0.001. a) Vitamin C 600 µg/ml, b) Vitamin B3 1200 µg/ml, c) Control (no vitamin B3 or 
C added), d) Vitamin C 1200 µg/ml, and e) Vitamin B3 600 µg/ml.  
 
Figure 3. Live/dead cell fluorescence image morphologies at day 7. The 1st column are 
images taken under bright-field (BF). The second column represents images of green fluorescent 
protein (GFP), where green indicates live cells. The third column represents images of red 
fluorescent protein (RFP), where red indicates dead cells. Images were taken at 10× 
magnifications. All of the images are grouped based on different types of organoids. a. represents 
129S ASF organoids, b. represents 129S ASF IL-10 knock-out organoids group, c. represents 
C3H ASF organoids, and d. represents C3H Conventional Raised organoids.  
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Figure 4. Live/dead cell fluorescence quantitative ratio at day 7. Fluorescence intensity from 
Live/Dead images were analyzed and the fluorescence intensity was measured. The y-axis is the 
ratio of the Live cell intensity divided by dead cell intensity. The higher the number, the more 
viable the cells are. The same data was used for plotting figure 4a and 4b in order to do different 
comparisons: under the same treatment groups or under the same type of organoids. A 
significance when comparing C3H Conv Control and Vitamin C 600 µg/ml groups was detected 
after an ANOVA test and Tukey test.  
 
Figure 5. Quantitative viability test results.  MTT assay was performed at day 7 of organoid 
growth. The same data was plotted differently for figure 5a and 5b in order to compare between 
the different groups. For 5a, organoids were compared under the same organoid type. For 5b, 
organoids were compared under the same concentration. For 5c, the p values for figure 5a are 
shown.  
 
Figure 6. Gene expression analysis. Comparisons were made between the experimental 
controls and other concentration groups (C600, C1200, B 600, and B 1200). CN: C3H 
Conventional Raised, CA: C3H ASF, 1A: 129 ASF, IL: 129 ASF IL-10. C600: Vitamin C 600 
µg/ml, C1200: Vitamin C 1200 µg/ml, B600: Vitamin B3 600 µg/ml, B1200: Vitamin B3 1200 
µg/ml. The heat map color represents averages of 2-∆∆CT values. P-values were calculated based 
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on an ANOVA test and Tukey tests with ∂ = 0.05. * p-value <0.05; ** p-value <0.01; *** p-
value <0.001.  
 
Figure 7. Gene expression analysis. 7a) Under the same experimental group (Control: No 
Vitamin Addition, C600, C1200, B 600, or B 1200), comparing 129 ASF gene expression with 
C3H ASF. 7b) Under same experimental group (Control: No Vitamin Addition, C600, C1200, B 
600, or B 1200), comparing 129 ASF gene expression with 129 ASF IL-10. 7c) Under same 
experimental group (Control: No Vitamin Addition, C600, C1200, B 600, or B 1200), comparing 
C3H ASF gene expression with C3H Conv. C600: Vitamin C 600 µg/ml, C1200: Vitamin C 
1200 µg/ml, B600: Vitamin B3 600 µg/ml, B1200: Vitamin B3 1200 µg/ml. The heat map color 
represents averages of 2-∆∆CT values. P-values were calculated based on ANOVA test and Tukey 
tests with ∂ = 0.05. * p-value <0.05; ** p-value <0.01; *** p-value <0.001.  
 
 
Gene Forward Reversed 
PIK3CA TCTGTCCTGGAACTCACTCT GTTGGCACACGCCTTTAATC 
CD44 TGGTGGTGGTATATCTGTTGTC GTACCTAGTGTACAATGGCTTCT 
Ki67 CCACACAGATGCCCTGTAAT CTCTACTTTCCCACGTCTTGTC 
NF-κB CTGAAGAACCTCCTGACTTCTG CATCTGCTGCTCCTACTCTATG 
Ceacam 12 ACAGCCTATGGTTGGCATATC TCCTCTGACCCACAGATACTT 
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MUC2 CTACCACCATTACCACCACTAC GTCTCTCGATCACCACCATTT 
IL-10 CCCTTTGCTATGGTGTCCTTTC AGGATCTCCCTGGTTTCTCTTC 
Rpl13a CACTCTGGAGGAGAAACGGAAGG GCAGGCATGAGGCAAACAGTC 
Table 1. Primers used for qPCR experiment.  
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